VHCP Management as of Sept. 30, 2013
Portfolio Holdings for VHCP Management
VHCP Management holds 18 positions in its portfolio as reported in the September 2013 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Dyax | 15.7 | $29M | 4.2M | 6.86 | |
| Ironwood Pharmaceuticals (IRWD) | 11.8 | $21M | 1.8M | 11.84 | |
| Keryx Biopharmaceuticals | 11.4 | $21M | 2.0M | 10.09 | |
| Anacor Pharmaceuticals In | 9.4 | $17M | 1.6M | 10.62 | |
| BioCryst Pharmaceuticals (BCRX) | 8.8 | $16M | 2.2M | 7.28 | |
| Gw Pharmaceuticals Plc ads | 8.0 | $15M | 838k | 17.34 | |
| Neurocrine Biosciences (NBIX) | 8.0 | $14M | 1.3M | 11.32 | |
| Tesaro | 5.6 | $10M | 261k | 38.74 | |
| Chelsea Therapeutics International | 4.2 | $7.5M | 2.5M | 2.99 | |
| Hyperion Therapeutics | 3.1 | $5.7M | 218k | 26.13 | |
| Vanda Pharmaceuticals (VNDA) | 3.0 | $5.4M | 491k | 10.95 | |
| Dbv Technologies | 2.8 | $5.1M | 480k | 10.61 | |
| Biodel | 2.2 | $4.0M | 1.3M | 3.15 | |
| Threshold Pharmaceuticals | 1.8 | $3.2M | 684k | 4.65 | |
| A.P. Pharma (APPA) | 1.7 | $3.1M | 9.1M | 0.34 | |
| Alexza Pharmaceuticals | 1.1 | $2.0M | 400k | 5.12 | |
| Ophthotech | 0.9 | $1.6M | 53k | 29.71 | |
| GTx | 0.6 | $1.0M | 500k | 2.03 |
